GENEVA, Feb. 18 -- ABBVIE INC. (1 North Waukegan RoadNorth Chicago, Illinois 60064) filed a patent application (PCT/US2024/041499) for "UPADACITINIB FOR TREATING ALOPECIA AREATA" on Aug 08, 2024. With publication no. WO/2025/034983, the details related to the patent application was published on Feb 13, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CHIRICOZZI, Andrea (Universita Cattolica del Sacro CuoreLargo Agostino Gemelli, 800168 Rome)
Abstract:
The present disclosure is directed to methods for treating alopecia areata (AA) using the selective JAK1 inhibitor upadacitinib.
For more...